Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy

Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathy

Abstract Achilles tendinopathy is a disabling condition that affects more than 50% of runners. Pre-clinical studies in a large animal model of naturally-occurring tendinopathy similar to human Achilles tendinopathy has shown benefits of autologous bone marrow-derived mesenchymal stem cell (MSC) impl...

Full description

Bibliographic Details
Main Authors: Andrew J. Goldberg, Lorenzo Masci, Paul O’Donnell, Ruth Green, Deirdre Brooking, Paul Bassett, Mark W. Lowdell, Roger K. W. Smith
Format: Article
Language:English
Published: Nature Portfolio 2024-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-61399-3

Internet

https://doi.org/10.1038/s41598-024-61399-3

Similar Items